- Home
- IDYA vs TRN Comparison
IDYA vs TRN Comparison
Compare IDYA & TRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- TRN
- Stock Information
- Founded
- IDYA 2015
- TRN 1933
- Country
- IDYA United States
- TRN United States
- Employees
- IDYA N/A
- TRN N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- TRN Railroads
- Sector
- IDYA Health Care
- TRN Industrials
- Exchange
- IDYA Nasdaq
- TRN Nasdaq
- Market Cap
- IDYA 1.9B
- TRN 2.1B
- IPO Year
- IDYA 2019
- TRN N/A
- Fundamental
- Price
- IDYA $21.23
- TRN $27.01
- Analyst Decision
- IDYA Strong Buy
- TRN Hold
- Analyst Count
- IDYA 13
- TRN 1
- Target Price
- IDYA $53.42
- TRN $24.00
- AVG Volume (30 Days)
- IDYA 1.1M
- TRN 630.4K
- Earning Date
- IDYA 08-05-2025
- TRN 07-31-2025
- Dividend Yield
- IDYA N/A
- TRN 4.42%
- EPS Growth
- IDYA N/A
- TRN 8.99
- EPS
- IDYA N/A
- TRN 1.63
- Revenue
- IDYA $7,000,000.00
- TRN $2,855,000,000.00
- Revenue This Year
- IDYA $101.20
- TRN N/A
- Revenue Next Year
- IDYA $286.70
- TRN $6.29
- P/E Ratio
- IDYA N/A
- TRN $16.67
- Revenue Growth
- IDYA N/A
- TRN N/A
- 52 Week Low
- IDYA $13.45
- TRN $23.01
- 52 Week High
- IDYA $44.42
- TRN $39.83
- Technical
- Relative Strength Index (RSI)
- IDYA 62.23
- TRN 58.40
- Support Level
- IDYA $21.08
- TRN $25.60
- Resistance Level
- IDYA $22.37
- TRN $27.24
- Average True Range (ATR)
- IDYA 0.92
- TRN 0.52
- MACD
- IDYA -0.09
- TRN 0.10
- Stochastic Oscillator
- IDYA 61.72
- TRN 85.98
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About TRN Trinity Industries Inc.
Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.